Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods

Details for Australian Patent Application No. 2006249497 (hide)

Owner Bristol-Myers Squibb Company

Inventors Devasthale, Pratik; Fevig, John M.; Hamann, Lawrence G.; O'Connor, Stephen P.; Wang, Wei

Agent A J Park

Pub. Number AU-A-2006249497

PCT Pub. Number WO2006/127287

Priority 60/682,968 20.05.05 US; 11/430,657 09.05.06 US

Filing date 11 May 2006

Wipo publication date 30 November 2006

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

Event Publications

22 November 2007 PCT application entered the National Phase

  PCT publication WO2006/127287 Priority application(s): WO2006/127287

8 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006249505-Enhanced flavor-release comestible compositions and methods for same

2006249494-Method of purifying Apo-2 ligand/TRAIL using crystallisation in the cold